Despite the project’s success, Trump repeatedly lashed out at the FDA for not approving the first COVID shots even sooner.

The nation's top vaccine regulator is stepping down — and he's not going quietly. Dr. Peter Marks, Director of the FDA’s ...

Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to ...

Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from ...

Genics is specifically formulated to support and maintain optimal eye health. It includes nutrients known to protect ...

A Department of Health and Human Services official delivered an ultimatum to Dr. Peter Marks: either resign or be fired.

Diopsys, Inc., a medical device manufacturer based in Middletown, Pennsylvania, will pay up to $14.25 million to resolve ...

Pantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...

Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

An estimated 45 million Americans wear them—and this recall affects at least two very recognizable brand names for eyes.

VUITY, an FDA-approved eye drop for presbyopia, has significant market potential given the growing aging population. With an estimated 128 million Americans affected by presbyopia, VUITY offers ...

DelveInsight's "VUITY Market Size, Forecast, and Market Insight Report" highlights the details around VUITY, which is a ...